Homechevron_rightAll Peptideschevron_rightSemax Injection Pen

verified_user

Safety data sheet

Standardized safety protocols and material specifications for professional use.

analytics

Certificate of Analysis

Purity verified via High-Performance Liquid Chromatography (HPLC) for #myo-semax-injection-pen-10mg

Official Product Data Sheet

Semax Injection Pen (10mg)

High >98% Purity

Vial Contents

10 mg Semax (3 mL pre-filled injection pen)

Includes

Ready-to-use multi-dose injection pen — no mixing or reconstitution required

Form

Pre-filled multi-dose injection pen

Purity

≥98%, third-party verified

Sequence

Met-Glu-His-Phe-Pro-Gly-Pro

Molecular Formula

C₃₇H₅₁N₉O₁₀S

Molecular Mass

813.92 g/mol

CAS No.

80714-61-0

Solubility

Concentration: ≈3.33 mg/mL | Per click: 1 unit ≈ 33.33 mcg (0.033 mg)

Storage

Refrigerate at 2–8 °C. Protect from light. Do not freeze.

Authorized Resellers

Available through our trusted partners

verifiedVerified

123peptide.com

Netherlands · Europe

local_shipping2-3 Business Days

Buy from Partneropen_in_new

verifiedVerified

Depeptidenwinkel.com

Netherlands · Europe

local_shipping2-3 Business Days

Buy from Partneropen_in_new

View all authorized resellersshopping_cart

swipe_rightSwipe to see all tabs

Scientific Background

Semax is a synthetic heptapeptide analog of ACTH(4–10) with a Pro-Gly-Pro extension, widely researched for its nootropic, neuroprotective, and neurorestorative properties without hormonal side effects. It rapidly increases BDNF and NGF expression in key brain areas, enhances monoamine signaling (dopamine and serotonin), promotes synaptic plasticity, and protects neurons from stress and oxidative damage. The pre-filled pen makes daily subcutaneous dosing simple and consistent.

Intended Research Use

Nootropic and cognitive performance research
BDNF and NGF upregulation studies
Neuroprotection and ischemia recovery models
Monoamine signaling and synaptic plasticity research
Attention, memory, and learning studies

menu_bookScientific Publications

article

BMC Genomics (2014)

The peptide semax affects the expression of genes related to the immune and vascular systems in rat brain focal ischemia

open_in_newhttps://pubmed.ncbi.nlm.nih.gov/24661642/

article

Zh Nevrol Psikhiatr Im S S Korsakova (2018)

The efficacy of semax in the treatment of patients at different stages of ischemic stroke

open_in_newhttps://pubmed.ncbi.nlm.nih.gov/29798983/

article

Mol Genet Mikrobiol Virusol (2008)

Effect of semax on BDNF and NGF gene expression in rat hippocampus and frontal cortex

open_in_newhttps://pubmed.ncbi.nlm.nih.gov/18720600/

warning

FOR RESEARCH USE ONLY. This product is intended for laboratory research purposes only and is not for human consumption, medical, or diagnostic use.

Possible stacks with other peptides

Synergistic combinations for enhanced research outcomes

Semax's BDNF-enhancing and monoamine-modulating effects pair well with other nootropic and neuroprotective peptides.

Selank 10mg (10mg vial)

arrow_forward

myo-selank-10mg

Classic Russian nootropic duo — Selank reduces anxiety and balances mood while Semax sharpens cognition, focus, and learning for comprehensive cognitive support.

Cerebrolysin 60mg (60mg vial)

arrow_forward

myo-cerebrolysin-60mg

Semax's neurotrophic BDNF/NGF boost combined with Cerebrolysin's broad neuroregeneration support for deeper neuroprotective research.

BPC-157 10mg (10mg vial)

arrow_forward

myo-bpc-157-10mg

Combines Semax's brain benefits with BPC-157's systemic repair and anti-inflammatory properties for mind-body recovery research.

schedule

Cycling Note: Typical protocol: 4–8 weeks on, 2 weeks off. At 600 mcg/day (~18 units), one 10 mg pen lasts approximately 16 days.

Also Available

Vial

Semax

10mg